Tampa General Hospital (TGH) has announced the opening of its new Outpatient Cellular Immunotherapy Transplant Unit at the TGH Cancer Institute.
This state-of-the-art facility is dedicated to providing advanced stem cell and cellular immunotherapy treatments for patients with aggressive blood cancers, including leukemias, lymphomas, and multiple myeloma.
The unit offers a comprehensive range of services, such as bone marrow transplants and innovative cellular therapies.
By focusing on outpatient care, TGH aims to enhance patient convenience and comfort while maintaining high-quality treatment standards.
Dr. Eduardo M. Sotomayor, director of the TGH Cancer Institute, emphasized the significance of this development, stating, “As we continue to build a Cancer Institute that is at the forefront of innovative treatments for patients with complex cancers, the establishment of our state-of-the-art BMT and Cell Therapies Unit will broaden the portfolio of groundbreaking and life-saving treatment options for cancer patients in our state and beyond.”
The launch of this unit aligns with TGH’s commitment to expanding access to cutting-edge cancer treatments and improving patient outcomes.
By integrating advanced stem cell therapies into their oncology services, TGH continues to position itself as a leader in comprehensive cancer care.
For more information about the TGH Cancer Institute and its services, visit https://www.tgh.org/institutes-and-services/cancer-institute
